These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7475580)

  • 1. HLA association with autoimmune disease: restricted binding or T-cell selection?
    Baum H; Wilson C; Tiwana H; Ahmadi K; Ebringer A
    Lancet; 1995 Oct; 346(8981):1042-3. PubMed ID: 7475580
    [No Abstract]   [Full Text] [Related]  

  • 2. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands.
    Muixí L; Carrascal M; Alvarez I; Daura X; Martí M; Armengol MP; Pinilla C; Abian J; Pujol-Borrell R; Jaraquemada D
    J Immunol; 2008 Jul; 181(1):795-807. PubMed ID: 18566446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
    Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE
    Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK
    J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rules governing peptide-class II MHC molecule interactions.
    Hammer J; Nagy ZA; Sinigaglia F
    Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
    [No Abstract]   [Full Text] [Related]  

  • 9. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions.
    Androulakis IP; Nayak NN; Ierapetritou MG; Monos DS; Floudas CA
    Proteins; 1997 Sep; 29(1):87-102. PubMed ID: 9294869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Eur J Med Chem; 2010 Jan; 45(1):236-43. PubMed ID: 19896246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential stability of HLA-DR alleles independent of endogenous peptides.
    Devaux B; Wilson KJ; Aguilar B; Jorgensen B; Rothbard JB
    J Immunol; 1995 Aug; 155(4):1921-9. PubMed ID: 7636243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical analysis of HLA-DRbeta1*0301-CLIP complex using the first three multipolar moments of the electrostatic field.
    Balbín A; Cárdenas C; Villaveces JL; Patarroyo ME
    Biochimie; 2006 Sep; 88(9):1307-11. PubMed ID: 16872734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between HLA-DR expression and level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells.
    Shinohara M; Morisawa K; Ota K; Qu Z; Takeda K; Hashimoto K; Tomoda T; Kurashige T; Taniguchi T
    Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):227-35. PubMed ID: 9130606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHCPred: A server for quantitative prediction of peptide-MHC binding.
    Guan P; Doytchinova IA; Zygouri C; Flower DR
    Nucleic Acids Res; 2003 Jul; 31(13):3621-4. PubMed ID: 12824380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.
    Li Y; Zhu Y; Zhou L; Fang Y; Huang L; Ren L; Peng Y; Li Y; Yang F; Xie D; Tang W; Zhang N; Zhong Q; Lai X
    Immunobiology; 2011 Aug; 216(8):947-60. PubMed ID: 21281984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases.
    Wucherpfennig KW; Strominger JL
    J Exp Med; 1995 May; 181(5):1597-601. PubMed ID: 7722439
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.
    Narayan K; Chou CL; Kim A; Hartman IZ; Dalai S; Khoruzhenko S; Sadegh-Nasseri S
    Nat Immunol; 2007 Jan; 8(1):92-100. PubMed ID: 17143275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules.
    Fridkis-Hareli M; Strominger JL
    J Immunol; 1998 May; 160(9):4386-97. PubMed ID: 9574543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.